Jeffrey T. Walsh, Chief Strategy Officer at bluebird bio, Inc. (BLUE), sold 3,000 shares at $139.80 ($419K) on 2019-03-11, disclosed to the SEC on 2019-03-13.
Seasonal sale ($419k) by Chief Strategy Officer — this insider has traded BLUE in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $139.80 | 1,500 | $210K | 50.0% |
| 2 | $139.80 | 1,500 | $210K | 50.0% |
| Total | $139.80 avg | 3,000 | $419K | 100% |
| Filing → |
| BLUE | SELL | 2019-06-12 | $176K | — | Filing → |
| BLUE | SELL | 2019-05-14 | $198K | — | Filing → |
| BLUE | SELL | 2019-04-12 | $298K | — | Filing → |